NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -175.00K | -294.00K | 216.30K | -280.40K | -271.20K |
| Total Depreciation and Amortization | 420.10K | 421.60K | 404.10K | 430.90K | 542.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 173.60K | 212.60K | 209.70K | 191.40K | 138.90K |
| Change in Net Operating Assets | -121.40K | 310.90K | 57.70K | -276.70K | 154.40K |
| Cash from Operations | 297.20K | 651.10K | 887.90K | 65.30K | 564.50K |
| Capital Expenditure | -192.20K | -148.10K | -314.20K | -34.90K | -88.20K |
| Sale of Property, Plant, and Equipment | 11.40K | -- | -- | -- | 0.00 |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | -129.80K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -180.70K | -148.10K | -314.20K | -164.70K | -88.20K |
| Total Debt Issued | -25.00K | 25.00K | -- | -- | 0.00 |
| Total Debt Repaid | -356.00K | -478.00K | -475.00K | -543.00K | -577.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -24.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 24.00K | 24.00K | 24.00K | 50.00K | 63.00K |
| Cash from Financing | -272.20K | -314.50K | -329.60K | -365.70K | -377.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.70K | 188.40K | 244.10K | -465.10K | 98.50K |